SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-18-009999
Filing Date
2018-07-16
Accepted
2018-07-13 18:18:08
Documents
44
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K form10-k.htm 10-K 630859
2 ex10-15.htm EX-10.15 64234
3 ex21-1.htm EX-21.1 2384
4 ex31-1.htm EX-31.1 12805
5 ex31-2.htm EX-31.2 12080
6 ex32-1.htm EX-32.1 6787
7 ex32-2.htm EX-32.2 5904
  Complete submission text file 0001493152-18-009999.txt   1910598

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE lwel-20180331.xml EX-101.INS 159996
9 XBRL SCHEMA FILE lwel-20180331.xsd EX-101.SCH 17780
10 XBRL CALCULATION FILE lwel-20180331_cal.xml EX-101.CAL 29607
11 XBRL DEFINITION FILE lwel-20180331_def.xml EX-101.DEF 57215
12 XBRL LABEL FILE lwel-20180331_lab.xml EX-101.LAB 132589
13 XBRL PRESENTATION FILE lwel-20180331_pre.xml EX-101.PRE 114465
Mailing Address ONE INTERNATIONAL PLACE, SUITE 1400 BOSTON MA 02110
Business Address ONE INTERNATIONAL PLACE, SUITE 1400 BOSTON MA 02110 (281) 668-2666
Luckwel Pharmaceuticals Inc. (Filer) CIK: 0001567098 (see all company filings)

IRS No.: 461660653 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 333-187874 | Film No.: 18953270
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1